B-lineage commitment prior to surface expression of B220 and CD19 on hematopoietic progenitor cellsMANSSON, Robert; ZANDI, Sasan; ANDERSON, Kristina et al.Blood. 2008, Vol 112, Num 4, pp 1048-1055, issn 0006-4971, 8 p.Article

SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies : Antibody Conjugates: The Futures Is NowBLANC, Veronique; BOUSSEAU, Anne; CARON, Anne et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6448-6458, issn 1078-0432, 11 p.Article

Defects in the CD19 complex predispose to glomerulonephritis, as well as IgG1 subclass deficiencyVINCE, Nicolas; BOUTBOUL, David; FIESCHI, Claire et al.Journal of allergy and clinical immunology. 2011, Vol 127, Num 2, pp 538-541, issn 0091-6749, 4 p.Article

Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer : state of the artPLEBANI, M; BASSO, D; PANOZZO, M. P et al.The International journal of biological markers. 1995, Vol 10, Num 4, pp 189-199, issn 0393-6155Article

B-cell Expansion and Lymphomagenesis Induced by Chronic CD40 Signaling Is Strictly Dependent on CD19HOJER, Caroline; FRANKENBERGER, Samantha; ZIMBER-STROBL, Ursula et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 16, pp 4318-4328, issn 0008-5472, 11 p.Article

An antibody-deficiency syndrome due to mutations in the CD19 geneVAN ZELM, Menno C; REISLI, Ismail; FRANCO, José L et al.The New England journal of medicine. 2006, Vol 354, Num 18, pp 1901-1912, issn 0028-4793, 12 p.Article

Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formationVAN ZELM, Menno C; SMET, Julie; VAN DER BURG, Mirjam et al.Human molecular genetics (Print). 2011, Vol 20, Num 9, pp 1854-1863, issn 0964-6906, 10 p.Article

Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disordersLEVESQUE, M. C.Clinical and experimental immunology (Print). 2009, Vol 157, Num 2, pp 198-208, issn 0009-9104, 11 p.Article

A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCRTORIKAI, Hiroki; REIK, Andreas; LEE, Dean A et al.Blood. 2012, Vol 119, Num 24, pp 5697-5705, issn 0006-4971, 9 p.Article

CD2+, CD3+, and CD19+ depletion after a course of antithymocyte globulin for a steroid-resistant rejectionGRANDTNEROVA, B; MOCIKOVA, H; KOHUTOVA, M et al.Transplantation proceedings. 1997, Vol 29, Num 7, pp 2958-2959, issn 0041-1345Conference Paper

In multiple myeloma, clonotypic B lymphocytes are detectable among CD19⁺ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chainBERGSAGEL, P. L; SMITH, A. M; SZCZEPEK, A et al.Blood. 1995, Vol 85, Num 2, pp 436-447, issn 0006-4971Article

Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human B-cell lines : an immunofluorescence and immunoelectron microscopy studyPULCZYNSKI, S; BOESEN, A. M; JENSEN, O. M et al.Blood. 1993, Vol 81, Num 6, pp 1549-1557, issn 0006-4971Article

Feedback suppression of B cell colony formation in healthy individualsFERNANDEZ, L. A; MACSWEEN, J. M; ROBSON, D. A et al.Clinical and experimental immunology (Print). 1989, Vol 78, Num 2, pp 314-319, issn 0009-9104Article

Loss of CD19 expression in B-cell neoplasmsMASIR, N; MARAFIOTI, T; JONES, M et al.Histopathology. 2006, Vol 48, Num 3, pp 239-246, issn 0309-0167, 8 p.Article

IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCTPFEIFFER, M. M; SCHUMM, M; MÜLLER, Ingo et al.Leukemia. 2012, Vol 26, Num 11, pp 2435-2439, issn 0887-6924, 5 p.Article

Activation of human B cells through the CD19 surface antigen results in homotypic adhesion by LFA-1-dependent and -independent mechanismsSMITH, S. H; RIGLEY, K. P; CALLARD, R. E et al.Immunology (Oxford). 1991, Vol 73, Num 3, pp 293-297, issn 0019-2805Article

Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19LEDBETTER, J. A; RABINOVITCH, P. S; JUNE, C. H et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 6, pp 1897-1901, issn 0027-8424Article

Association of a functional CD19 polymorphism with susceptibility to systemic sclerosisTSUCHIYA, Naoyuki; KUROKI, Kimiko; FUJIMOTO, Manabu et al.Arthritis and rheumatism. 2004, Vol 50, Num 12, pp 4002-4007, issn 0004-3591, 6 p.Article

Reciprocal alteration in circulating TJ6+ CD19+ and TJ6+ CD56+ leukocytes in early pregnancy predicts success or miscarriageCOULAM, C. B; BEAMAN, K. D.American journal of reproductive immunology (1989). 1995, Vol 34, Num 4, pp 219-224, issn 1046-7408Conference Paper

CD19 : lowering the threshold for antigen receptor stimulation of B lymphocytesCARTER, R. H; FEARON, D. T.Science (Washington, D.C.). 1992, Vol 256, Num 5053, pp 105-107, issn 0036-8075Article

Selective killing of normal and neoplastic human B cells with anti-CD19- and anti-CD22-ricin A chain immunotoxinsMAY, R. D; VITETTA, E. S; MOLDENHAUER, G et al.Cancer drug delivery. 1986, Vol 3, Num 4, pp 261-272, issn 0732-9482Article

Generation of CD19-chimeric antigen receptor modified CD8⁺ T cells derived from virus-specific central memory T cellsTERAKURA, Seitaro; YAMAMOTO, Tori N; GARDNER, Rebecca A et al.Blood. 2012, Vol 119, Num 1, pp 72-82, issn 0006-4971, 11 p.Article

Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinaseAIBA, Yuichi; KAMEYAMA, Megumi; YAMAZAKI, Tetsuo et al.Blood. 2008, Vol 111, Num 3, pp 1497-1503, issn 0006-4971, 7 p.Article

Developmental hierarchy during early human B-cell ontogeny after autologous bone marrow transplantation using autografts depleted of CD19⁺ B-cell precursors by an anti-CD19 Pan-B-cell immunotoxin containing pokeweed antiviral proteinUCKUN, F. M; HAISSING, S; LEDBETTER, J. A et al.Blood. 1992, Vol 79, Num 12, pp 3369-3379, issn 0006-4971Article

Potent In vitro and In vivo Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and LeukemiaHORTON, Holly M; BERNETT, Matthew J; DESJARLAIS, John R et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 19, pp 8049-8057, issn 0008-5472, 9 p.Article